2 PUFFS OF BEVESPI AEROSPHERE TWICE A DAY, EVERY DAY
Before starting BEVESPI AEROSPHERE, read the Instructions for Use that comes with your prescription. If you have any questions about the directions, ask your health care provider.
PREPARING YOUR INHALER+
PREPARING YOUR INHALER
Take your inhaler out of the foil pouch. Throw the foil pouch away, along with the drying packet that came with it. There are...
Parts of your BEVESPI AEROSPHERE inhaler:
There are five main components of your inhaler: the Cap, the Mouthpiece, the Actuator, the Canister, and the Dose Indicator.
Before you start using your BEVESPI AEROSPHERE inhaler, it’s important that you understand how the dose indicator on your inhaler works.
Make sure that the pointer on the dose indicator is pointing to the right of the “120” mark in the display window.
After 10 puffs are delivered, the pointer will point to 120. This means that there are 120 puffs of medicine left in the canister.
After you take 10 more puffs, the pointer will be pointing between 100 and 120, meaning there are 110 puffs left in the canister.
And 10 puffs after that, the pointer will point to 100, meaning 100 puffs are left.
The dose indicator display window will continue to move after every 10 puffs. The number in the dose indicator display window will continue to change after every 20 puffs. The color in the dose indicator display window will change to red when there are only 20 puffs of medicine left in your inhaler.
Now let’s review priming.
PRIMING YOUR INHALER FOR THE FIRST TIME+
PRIMING YOUR INHALER FOR THE FIRST TIME
To prime your inhaler, remove the cap from the mouthpiece and make sure it’s clear and free of any objects. Hold the...
inhaler in the upright position, pointing away from your face, and shake the inhaler well.
Now, press down firmly on the center of the dose indicator until the canister stops moving in the actuator, to release a puff of medicine from the mouthpiece. You may hear a soft click as the indicator counts down.
Repeat these priming steps 3 more times. Don’t forget to shake the inhaler well before each priming puff. After priming 4 times, the dose indicator should be pointing to the right of the “120” and your inhaler is now ready to use.
USING YOUR INHALER+
USING YOUR INHALER
STEP 1. Remove the cap from the mouthpiece and shake the inhaler well before each use...
STEP 2. Hold the inhaler with the mouthpiece pointing towards you and breathe out as fully as you comfortably can through your mouth.
STEP 3. Close your lips around the mouthpiece. Tilt your head back, keeping your tongue below the mouthpiece.
STEP 4. While breathing in deeply and slowly, press down on the center of the dose indicator until the canister stops moving in the actuator and a puff of medicine is released. Then, stop pressing the dose indicator.
STEP 5. When you have finished breathing in, remove the mouthpiece from your mouth and hold your breath as long as you comfortably can, up to 10 seconds. Then, breathe out gently.
Now, repeat the steps above to take your second puff of BEVESPI AEROSPHERE. Then, replace the cap over the mouthpiece right away after use.
CLEANING YOUR INHALER+
CLEANING YOUR INHALER
It is very important that you clean your inhaler 1 time each week to prevent medicine from building up and blocking the spray...
through the mouthpiece.
STEP 1. Take the canister out of the actuator and remove the cap from the mouthpiece. Don’t clean the canister or let it get wet.
STEP 2. Hold the actuator under the faucet and run warm water through it for about 30 seconds. Then turn it upside down and rinse it again through the mouthpiece for about 30 seconds.
STEP 3. Shake off the water from the actuator, and look into the actuator and mouthpiece to make sure any medicine build-up has been completely washed away. If there is any build-up, repeat step 2 and this step.
STEP 4. Let the actuator air-dry overnight. Remember not to put the canister back into the actuator if it’s still wet.
STEP 5. When the actuator is dry, gently press the canister down in the actuator. Don’t press too hard or it could cause a puff of medicine to be released.
After each cleaning, it’s important to re-prime your inhaler. This is done by pressing down on the center of the dose indicator 2 times to release a total of 2 puffs into the air, away from your face. Don't forget to shake the inhaler well before each re-priming puff. Your inhaler is now ready to use.
If you do not use your BEVESPI AEROSPHERE for more than 7 days, you will need to re-prime before use, as described above.
Thank you for taking the time to learn about your BEVESPI AEROSPHERE Inhaler. If you have any questions, be sure to ask your health care professional.
People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as formoterol fumarate (one of the medicines in BEVESPI AEROSPHERE), have an increased risk of death from asthma problems. It is not known if LABA medicines increase the risk of death in people with COPD. BEVESPI AEROSPHERE is only approved for use in COPD. BEVESPI AEROSPHERE is not approved for use in asthma.
- Call your healthcare provider if breathing problems worsen over time while using BEVESPI AEROSPHERE
- Get emergency medical care if your breathing problems worsen quickly or if you use your rescue inhaler, but it does not relieve your breathing problems
- Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD. Always have a rescue inhaler with you to treat sudden symptoms
- BEVESPI AEROSPHERE is not for the treatment of asthma. It is not known if BEVESPI AEROSPHERE is safe and effective in people with asthma
- Do not use BEVESPI AEROSPHERE if you are allergic to glycopyrrolate, formoterol fumarate, or to any of the ingredients in BEVESPI AEROSPHERE
- Do not use BEVESPI AEROSPHERE more often than prescribed
- Do not take BEVESPI AEROSPHERE with other medicines that contain a LABA or an anticholinergic for any reason. Tell your healthcare provider about all the medicines you take
- Tell your healthcare provider about all your medical conditions including heart problems, high blood pressure, seizures, thyroid problems, diabetes, liver problems, glaucoma, prostate or bladder problems, or problems passing urine
BEVESPI AEROSPHERE can cause serious side effects, including:
- Sudden breathing problems immediately after inhaling your medicine
- Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of the face, mouth and tongue; breathing problems
- Fast or irregular heartbeat, increased blood pressure, chest pain
- Tremor or nervousness
- New or worsened eye problems, including acute narrow-angle glaucoma. Symptoms may include: eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose
- New or worsened urinary retention. Symptoms may include difficulty urinating, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking BEVESPI AEROSPHERE and call your healthcare provider right away
- High blood sugar or low blood potassium
Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. Tell your healthcare provider about any side effect that bothers you or that does not go away.
BEVESPI AEROSPHERE is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. BEVESPI AEROSPHERE is used long term as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing. Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD; it won't replace a rescue inhaler. BEVESPI AEROSPHERE is not for the treatment of asthma.
People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as formoterol fumarate (one of the medicines in BEVESPI AEROSPHERE), have an increased risk of death from asthma problems. It is not known if LABA medicines increase the risk of death in people with COPD.